Mechanisms of Venous Thrombosis and Resolution
Top Cited Papers
Open Access
- 1 March 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 28 (3) , 387-391
- https://doi.org/10.1161/atvbaha.108.162289
Abstract
Venous thromboembolism is a significant health care problem in the US. In this review, the unique role of inflammation to the venous thrombotic process is emphasized as well as the potential role of abnormalities of fibrinolytic mechanisms to the thrombotic process. Inflammation influences not only thrombogenesis but also thrombus resolution and vein wall remodeling, and these interactions are also discussed. Knowledge of molecular and immunologic mechanisms for venous thrombosis and its resolution should allow for the future development of targeted therapies.Keywords
This publication has 49 references indexed in Scilit:
- Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesisThrombosis and Haemostasis, 2007
- Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosisJournal of Vascular Surgery, 2006
- Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse modelJournal of Vascular Surgery, 2005
- ADAMTS13 turns 3Blood, 2005
- Inflammation-dependent thrombosisFrontiers in Bioscience-Landmark, 2005
- D-dimer, P-selectin, and microparticles: Novel markers to predict deep venous thrombosisThrombosis and Haemostasis, 2005
- Deep vein thrombosis resolution is not accelerated with increased neovascularizationJournal of Vascular Surgery, 2004
- Neutropenia impairs venous thrombosis resolution in the ratJournal of Vascular Surgery, 2003
- The Endothelium and ThrombosisSeminars in Thrombosis and Hemostasis, 2000
- Plasminogen-Activator Inhibitor Type 1 and Coronary Artery DiseaseNew England Journal of Medicine, 2000